Skip to content
10-Q

Quarterly Report

Regulus Therapeutics Inc.

0001628280-24-036174

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 2, 2024 65.47M sh
Shares Diluted Q2 2024 · Jun 30, 2024 64.47M sh
Shares Diluted Q2 2024 · Jun 30, 2024 47.11M sh
Shares Diluted Q2 2024 · Jun 30, 2023 19.1M sh
Shares Diluted Q2 2024 · Jun 30, 2023 17.98M sh
Capex Q2 2024 · Jun 30, 2024 $312K
Capex Q2 2024 · Jun 30, 2023 $1K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$20.38M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$14.37M
Short Term Debt Q2 2024 · Jun 30, 2024 $0
Short Term Debt Q2 2024 · Dec 31, 2023 $1.33M
Short Term Investments Q2 2024 · Jun 30, 2024 $77.34M
Short Term Investments Q2 2024 · Dec 31, 2023 $0
Cash And Equivalents Q2 2024 · Jun 30, 2024 $17.12M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $23.77M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $37.26M
Stockholders Equity Q2 2024 · Jun 30, 2024 $98.18M
Stockholders Equity Q2 2024 · Mar 31, 2024 $107.59M
Stockholders Equity Q2 2024 · Dec 31, 2023 $21.19M
Stockholders Equity Q2 2024 · Jun 30, 2023 $34M
Stockholders Equity Q2 2024 · Mar 31, 2023 $26.6M
Stockholders Equity Q2 2024 · Dec 31, 2022 $33.29M
Current Liabilities Q2 2024 · Jun 30, 2024 $5.26M
Current Liabilities Q2 2024 · Dec 31, 2023 $8.51M
Total Liabilities Q2 2024 · Jun 30, 2024 $5.94M
Total Liabilities Q2 2024 · Dec 31, 2023 $9.56M
Current Assets Q2 2024 · Jun 30, 2024 $100.34M
Current Assets Q2 2024 · Dec 31, 2023 $28.18M
Total Assets Q2 2024 · Jun 30, 2024 $104.12M
Total Assets Q2 2024 · Dec 31, 2023 $30.75M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.17
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.41
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.37
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.79
Eps Basic Q2 2024 · Jun 30, 2024 −$0.17
Eps Basic Q2 2024 · Jun 30, 2024 −$0.41
Eps Basic Q2 2024 · Jun 30, 2023 −$0.37
Eps Basic Q2 2024 · Jun 30, 2023 −$0.79
Sga Expense Q2 2024 · Jun 30, 2024 $3.95M
Sga Expense Q2 2024 · Jun 30, 2024 $6.74M
Sga Expense Q2 2024 · Jun 30, 2023 $2.34M
Sga Expense Q2 2024 · Jun 30, 2023 $4.78M
Rd Expense Q2 2024 · Jun 30, 2024 $8.31M
Rd Expense Q2 2024 · Jun 30, 2024 $14.35M
Rd Expense Q2 2024 · Jun 30, 2023 $4.98M
Rd Expense Q2 2024 · Jun 30, 2023 $9.9M
Net Income Q2 2024 · Jun 30, 2024 −$11.04M
Net Income Q2 2024 · Jun 30, 2024 −$19.51M
Net Income Q2 2024 · Mar 31, 2024 −$8.47M
Net Income Q2 2024 · Jun 30, 2023 −$7.01M
Net Income Q2 2024 · Jun 30, 2023 −$14.15M
Net Income Q2 2024 · Mar 31, 2023 −$7.14M
Operating Income Q2 2024 · Jun 30, 2024 −$12.26M
Operating Income Q2 2024 · Jun 30, 2024 −$21.09M
Operating Income Q2 2024 · Jun 30, 2023 −$7.32M
Operating Income Q2 2024 · Jun 30, 2023 −$14.68M